FDA Cites Facilities in China, Japan, and India Post author:Sam Post published:February 14, 2017 Post category:Drug Industry Daily The FDA issued warning letters to four overseas manufacturers over GMP and other failures. Source: Drug Industry Daily You Might Also Like FDA Issues Final Guidance on BsUFA II Fees June 28, 2018 Oklahoma Medicaid Implements Value-Based Drug Purchasing August 21, 2018 Florida Compounding Pharmacy Broke GMP Rules, FDA Says October 25, 2017